Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What CAGR is Anticipated for the Cell and Gene Therapy Market During the Forecast Period, and Why?

The cell and gene therapy market size has expanded exponentially in recent years. It is forecasted to rise from $12.01 billion in 2024 to $15.48 billion in 2025, with a remarkable CAGR of 28.9%. The key drivers of past growth include increased investment in cell and gene therapies, advancements in research and development, breakthroughs in cancer drug discovery, a rise in public-private collaborations, strong economic growth in emerging markets, greater healthcare expenditures, and an increase in pharmaceutical R&D spending.

The cell and gene therapy market is expected to grow rapidly, reaching $29.15 billion by 2029, with a CAGR of 17.1%. Growth is attributed to the rising prevalence of cancer and chronic diseases, aging populations, and increased healthcare spending. Key trends include advanced therapies like CAR T-cell therapy, research funding, gene editing tools, strategic partnerships, and expanding pipeline studies.

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of the cell and gene therapy Market?

The steady investment and consolidation in cell and gene therapies are contributing to the growth of the cell and gene therapy (CGT) market. Biopharmaceutical companies are increasingly investing in CGT, with 16 out of the 20 largest companies adding CGT products to their portfolios. For instance, UK-based Purespring Therapeutics received $105 million in funding in October 2024 to support the development of gene therapies. This investment in CGT production capacity is driving the market’s growth.

Request Your Free Cell and Gene Therapy Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=3472&type=smp

Which Companies Are Poised to Shape the Future of the Cell and Gene Therapy Market?

Major companies operating in the cell and gene therapy market include:

• Biogen Inc._x000D_

• Novartis AG_x000D_

• Gilead Sciences_x000D_

• Ionis Pharmaceuticals Inc._x000D_

• Alnylam Pharmaceuticals Inc._x000D_

What Are the Latest Innovations and Trends Influencing the Cell and Gene Therapy Market?

In the cell and gene therapy (CGT) market, chimeric antigen receptor (CAR) T-cell therapy is making significant strides. CAR-T therapy involves genetically modified T cells to target cancer cells. For example, in June 2022, Bristol-Myers Squibb received U.S. FDA approval for Breyanzi, a CAR T-cell therapy for large B-cell lymphoma. This therapy is made from a patient’s own T cells, which are genetically engineered to target cancer cells effectively.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/cell-and-genes-therapy-global-market-report

Which Industry Segments Are Leading the Development and Expansion of the Cell and Gene Therapy Market?

The cell and gene therapy market covered in this report is segmented –

1) By Product: Cell Therapy, Gene Therapy

2) By Application: Oncology, Neurological Disorders, Other Applications

3) By End User: Hospitals, Ambulatory Surgical Centers, Cancer Care Centers, Wound Care Centers, Other End-Users

Subsegments:

1) By Cell Therapy: Autologous Cell Therapy, Allogeneic Cell Therapy, Stem Cell Therapy, CAR-T Cell Therapy

2) By Gene Therapy: Viral Vector-Based Gene Therapy, Non-Viral Vector-Based Gene Therapy, Genome Editing Technologies, Antisense Oligonucleotide Therapy

What Regions Are Contributing Significantly to the Growth of the Cell and Gene Therapy Market?

North America was the largest region in the cell and gene therapy market in 2024. The regions covered in the cell and gene therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

How Is the Scope and Reach of the Cell and Gene Therapy Market Defined?

Gene therapy involves the transmission of genetic material, typically in the form of a carrier or vector, and the uptake of the gene into the proper body cells. Cell therapy includes introducing cells into the patient with the appropriate function. Some procedures combine cell therapy with gene therapy.

Browse Through More Similar Reports By The Business Research Company:

nucleic acid based gene therapy market, global nucleic acid based gene therapy market, nucleic acid based gene therapy market trends, nucleic acid based gene therapy market forecast, nucleic acid based gene therapy market analysis, nucleic acid-based therapeutics market, nucleic acid based gene therapy global market report 2021, nucleotide therapy market, gene therapy industry report, nucleic acid based gene therapy market report 2020

https://www.thebusinessresearchcompany.com/report/nucleic-acid-based-gene-therapy-global-market

Alpha Mannosidosis Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/alphas-mannosidosis-global-market-report

Induced Pluripotent Stem Cell (iPSC) Global Market Opportunities And Strategies To 2031

https://www.thebusinessresearchcompany.com/report/induced-pluripotent-stem-cell-market

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: